Table 3.
Ref. | Design | Cases | Technical success | Clinical success | Recurrence | Complications1 |
Seewald et al[70] | RS | 13 | 100% | 85% | 15% | 30% |
Charnley et al[71] | RS | 13 | 100% | 92% | 0% | None |
Voermans et al[72] | RS | 25 | 100% | 93% | 7% | 40% |
Hocke et al[73] | RS | 30 | 97% | 83% | 3% | 23% |
Schrover et al[74] | RS | 8 | 100 % | 75% | 12% | 25% |
Mathew et al[75] | RS | 6 | 100% | 100% | 0% | None |
Escourrou et al[76] | RS | 13 | 100% | 100% | 0% | 46% |
Jürgensen et al[77] | RS | 35 | 100% | 97% | 0% | 17% |
Bakker et al[78] | RCT | 10 | 100% | 100% | 20% | 40% |
Will et al[79] | RS | 18 | 100% | 100% | 11% | 17% |
Rische et al[61] | RS | 22 | 100% | 86% | 14% | 36% |
Yamamoto et al[80] | RS | 4 | 100% | 50% | NR | 25% |
Hritz et al[81] | RS | 4 | 100% | 100% | 0% | None |
Yasuda et al[82] | RS | 57 | 100% | 75% | 7% | 33% |
Ang et al[83] | RS | 8 | 100% | 87% | 13% | None |
Sarkaria et al[84] | RS | 17 | 100% | 88% | 0% | 6% |
Total | 16 studies | 283 | 100% (97%-100%) | 88% (50%-100%) | 7% (0%-20%) | 28% (0%-46%) |
Complications include: early and late, procedural and stent related. RCT: Randomized controlled trial; PS: Prospective study; RS: Retrospective study; NR: Not reported.